http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14745553

Outgoing Links

Predicate Object
contentType Editorial|Research Support, N.I.H., Intramural
endingPage 904
issn 1354-3784
1744-7658
issueIdentifier 7
pageRange 901-904
publicationName Expert Opinion on Investigational Drugs
startingPage 901
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
bibliographicCitation Marchand C. The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet. Expert Opinion on Investigational Drugs. 2012 May 10;21(7):901–4. doi: 10.1517/13543784.2012.685653.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e26db26f61e157914a23f070d3152ac3
date 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1517/13543784.2012.685653
https://pubmed.ncbi.nlm.nih.gov/22571404
isPartOf https://portal.issn.org/resource/ISSN/1744-7658
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21889
https://portal.issn.org/resource/ISSN/1354-3784
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet
discusses http://id.nlm.nih.gov/mesh/M0571031
http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0526043
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0003327
http://id.nlm.nih.gov/mesh/M0020993
http://id.nlm.nih.gov/mesh/M0000347
http://id.nlm.nih.gov/mesh/M0006823
http://id.nlm.nih.gov/mesh/M000606070
http://id.nlm.nih.gov/mesh/M0028839
http://id.nlm.nih.gov/mesh/M0023650
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013844Q000008
http://id.nlm.nih.gov/mesh/D002219Q000008
http://id.nlm.nih.gov/mesh/D003841Q000627
http://id.nlm.nih.gov/mesh/D063065Q000008
http://id.nlm.nih.gov/mesh/D063065Q000627
http://id.nlm.nih.gov/mesh/D019380Q000008
http://id.nlm.nih.gov/mesh/D003841Q000008
http://id.nlm.nih.gov/mesh/D013844Q000627
http://id.nlm.nih.gov/mesh/D015363Q000008
http://id.nlm.nih.gov/mesh/D019380Q000627
http://id.nlm.nih.gov/mesh/D002219Q000627
http://id.nlm.nih.gov/mesh/D015363Q000627
http://id.nlm.nih.gov/mesh/D000225Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000225Q000008
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D000069545
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D004338
http://id.nlm.nih.gov/mesh/D015658Q000188
http://id.nlm.nih.gov/mesh/D013607
http://id.nlm.nih.gov/mesh/D023241
http://id.nlm.nih.gov/mesh/D000225Q000627
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5277135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25151504

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247090214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129727356

Total number of triples: 63.